[go: up one dir, main page]

Barr et al., 2012 - Google Patents

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion

Barr et al., 2012

View PDF
Document ID
6202224302947641505
Author
Barr P
Wei C
Roger J
Schaefer-Cutillo J
Kelly J
Rosenberg A
Jung J
Sanz I
Friedberg J
Publication year
Publication venue
Clinical Immunology

External Links

Snippet

Cell signaling initiated by the B cell receptor is critical to normal development of B lymphocytes, most notably at the transitional B cell stage. Inhibition of this signaling pathway with the syk inhibitor, fostamatinib, has produced significant efficacy in lymphoid …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms

Similar Documents

Publication Publication Date Title
Kovtonyuk et al. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice
Eaves Hematopoietic stem cells: concepts, definitions, and the new reality
Ponzetta et al. Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors
Metcalfe et al. Pathogenesis and pathology of mastocytosis
Arock et al. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
Young et al. Targeting pathological B cell receptor signalling in lymphoid malignancies
Knippenberg et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Rosenkranz et al. Zinc supplementation induces regulatory T cells by inhibition of Sirt‐1 deacetylase in mixed lymphocyte cultures
Chabbi-Achengli et al. Decreased osteoclastogenesis in serotonin-deficient mice
Martínez-Cué et al. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome
Mócsai et al. Syk is required for integrin signaling in neutrophils
Ponader et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Barr et al. Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion
Mongini et al. TLR-9 and IL-15 synergy promotes the in vitro clonal expansion of chronic lymphocytic leukemia B cells
D D'Souza et al. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia
de Leseleuc et al. PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages
Herrera et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease
Winer et al. PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies
Burger Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemia
EP3433365B1 (en) T-cell exhaustion state-specific gene expression regulators and uses thereof
Yazicioglu et al. Dynamic mitochondrial transcription and translation in B cells control germinal center entry and lymphomagenesis
Mizoguchi et al. Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib
Kurkó et al. Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow
Uehara et al. Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
Chen et al. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases